The dosing schedule involves daily injections for five consecutive days each week, followed by two days off
What sets Ipamorelin apart from other peptides in the GHRP class is its exceptional selectivity
Insulin growth factor-1 (IGF-1) enhances hippocampal excitatory and seizure activity through IGF-1 receptor-mediated mechanisms in the epileptic brain
Important Safety Information Peptides such as CJC-1295 and Ipamorelin : Are not FDA-approved for any specific medical condition Are intended for research purposes only Must be used only under supervision of a licensed physician trained in peptide therapy Are only available to established patients of our clinic
View Study [3]"Once-daily administration of CJC-1295 normalizes growth in the GHRH knockout mouse" Alba M, Fintini D, Sagazio A et al., 2006 Finding: Daily CJC-1295 treatment restored normal body weight, length, and body composition in growth hormone-deficient mice, demonstrating its ability to normalize GH-dependent growth